Scientists from the BRAINCITY center of excellence at the Nencki Institute of the Polish Academy of Sciences (PAN) have developed an experimental targeted therapy for autism. This is a breakthrough in understanding the treatment options for the symptoms of this complex disorder.
Their findings were published in the leading American scientific journal Molecular Psychiatry. The Research Center for Neural Plasticity and Brain Diseases BRAINCITY is co-financed by European funds as part of the International Research Agendas program of the Foundation for Polish Science.
According to the press release of the Foundation for Polish Science, Dr Alicja Puścian and the research team led by Prof. Ewelina Knapska at the Research Center for Neural Plasticity and Brain Diseases BRAINCITY at the Nencki Institute of the Polish Academy of Sciences showed that an experimental therapy adapted to the specific symptoms of autism is not only possible, but also effective.